Pharmaceutical Glass Packaging Market Healthy Pace throughout 2027

The global market for pharmaceutical glass packaging is expected to exhibit a CAGR of 4.1% in the course of the forecast period 2017 to 2027.

A new report published by Persistence Market Research titled "Pharmaceutical Glass Packaging Market: Global Industry Analysis 2012 - 2016 and Forecast 2017 - 2027," states that the emphasis on chemical and delamination resistant packaging is rising as pharmaceutical manufacturers are eyeing high delamination resistance packaging in their products to extend the shelf life. Moreover, the latest pharmaceutical drugs need a considerably high barrier protection from oxygen and water vapor which is easily achieved by type I borosilicate glass packaging. Understanding the pharmaceutical manufacturers' needs and offering products accordingly with specified characteristics and sustaining a proper value chain in order to decrease the price of the final product are the key concerns of market players. Offering innovative products and variants is an intensifying trend among manufacturers in the global pharmaceutical glass packaging market. More focus is being directed towards the manufacturing of products that are associated with the convenience of manufacturers and consumers in order to leverage opportunities arising from the proliferating demand for pharmaceutical products.

Request the sample copy of report @ https://www.persistencemarketresearch.com/samples/3778

Advanced Materials to be a Core Preference of Pharmaceutical Manufacturers
A latest trend that is being witnessed in the global pharmaceutical glass packaging market is the adoption of optimized Siliconization and UV Curing techniques during the manufacturing process of syringes. Moreover, pharmaceutical companies prefer tungsten free or low tungsten glass syringes for their products to avoid any contamination. During Siliconization control, it is ensured that the silicon is distributed equally inside the container. Companies are innovating existing safety devices to promise zero needle stick injuries. The conventional devices require manual activation by the user to trigger the needle shield. However, the latest technological advancements have led to the introduction of pre-filled syringes integrated devices that are passively activated and are available in a ready-to-use preassembled format. Furthermore, the demand for ready-to-use containers has increased extensively over the last couple years which is further creating room for changes in the existing product portfolio backed by high innovation. Some of the primary needs of the pharmaceutical industry are increasing quality, reducing TCO, enhancing flexibility, and reducing the time to market.

Biologic drug formulations are becoming the primary focus for treatment of many diseases from cell and gene therapies to immunotherapeutics. New formulations are being discovered every day for several treatments. This has led to incompatibility of the existing traditional packaging formats and the need for innovation has arisen in the pharmaceutical glass packaging market. More and more biologics drugs require ready-to-use packaging solutions and market demand for the same is fulfilled by prefilled syringes. Prefilled syringes ensure the accuracy of the doses with ready-to-use compatibility. The demand for such type of packaging products is increasing at a very fast pace in developed as well as emerging economies.

Request For Report Customization @ https://www.persistencemarketresearch.com/request-customization/3778

Key Players :
• Schott AG
• Gerresheimer AG
• Becton, Dickinson and Company
• Owens-Illinois, Inc.
• Ardagh Group S.A.
• Nipro Corporation
• West Pharmaceutical Services, Inc.
• Stevanato Group (Ompi)
• O.Berk Company, LLC
• ?i?ecam Group
• DWK Life Sciences GmbH
• Beatson Clark Ltd.
• Piramal Glass Limited
• Acme Vial and Glass Company, LLC
• Amposan S.A.
• SGD Pharma
• Hindusthan National Glass & Industries Limited
• Shandong Pharmaceutical Glass Co., Ltd.
• Bormioli Pharma Srl
• Agrado S.A.
• Others.

Contact Sales for Further Assistance in Purchasing This Report@ https://www.persistencemarketresearch.com/checkout/3778

Injectable to Lead in Terms of Application
Injectable is expected to lead the global market for pharmaceutical glass packaging by the end of the forecast period owing to its high penetration in the coming years. The other applications for pharmaceutical glass packaging include oral, nasal, and others such as topical among others. Region-wise, the market has been segmented into North America, Europe, APAC, Latin America, and the Middle East and Africa.

Innovation to be a Core Focus of Manufacturers
Manufacturers are focusing on innovating in terms of product design and features such as introduction of glass prefilled syringes and high usage of Type I borosilicate glass for the manufacturing of containers. The pharmaceutical glass packaging market is dominated by some of the global manufacturers such as Nipro Corporation, Gerresheimer AG, Schott AG, and Stevanato Group. All of these companies together account for almost 30%-40% of the overall market.

Read More Trending "PMR Exclusive Article"-
https://www.prnewswire.com/news-releases/worldwide-pharmaceutical-glass-packaging-market-to-reach-us-8000-mn-by-2027-persistence-market-research-674153303.html

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
The Consumer Goods team at Persistence Market Research helps clients from all over the globe with their unique business intelligence needs by offering expert analysis, actionable insights, and strategic recommendations. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the consumer goods industry lucidly in 50+ countries for over a decade. We provide end-to-end research and consulting services; reach out to explore how we can help.

This release was published on openPR.